Method for detecting Paxonin in cosmetics and application of Paxonin
Through high-performance liquid chromatography-mass spectrometry tandem meter combined with methanol extraction and mobile phase conditions of ammonium formate and acetonitrile formate solutions, the problem of insufficient sensitivity and range of Pionylenes detection in cosmetics was solved, and the liquid, emulsion and cream matrix was realized. Pi Aoning's precise inspection ensures cosmetic quality control.
Patent Information
- Application Number
- CN202411247836.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-06
- Publication Date
- 2024-11-19
AI Technical Summary
The prior art lacks effective detection methods to accurately determine the content of Piconin in cosmetics, especially in liquid matrix, emulsion matrix and cream matrix, and the existing methods have low sensitivity and limited application range.
The high-performance liquid chromatography-mass spectrometry tandem meter combined with methanol extraction and the mobile phase conditions of mixed solutions of ammonium formate and acetonitrile formate, and the precise detection of Pionylon was achieved through ultrasonic extraction and centrifugation steps.
It provides a method that can accurately detect the content of Pionylon in cosmetics, fills the market gap, ensures the quality control of Pionylon in cosmetics, is suitable for cosmetics with complex substrates, and improves the sensitivity and range of detection.
Smart Images

Figure CN118980773A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of detection technology, and in particular to a method for detecting pionin in cosmetics and application thereof. Background Art
[0002] The chemical name of Pionin is (Z)-3-heptyl-2-((3-heptyl-4-methylthiazol-2(3H)-ylidene)methyl)-4-methylthiazol-3-ium iodide, and its English name is 3-heptyl-2-[(3-heptyl-4-methyl-3H-thiazol-2-ylidene)methyl]-4-methylthiazolium iodide). It has strong antibacterial activity and can effectively inhibit Propionibacterium acnes, Staphylococcus epidermidis and Staphylococcus aureus. It is often used as an anti-acne ingredient in cosmetics. In recent years, studies have found that it also has bactericidal, whitening, antiseptic, conditioning, and anti-dandruff effects, and has broad application prospects in the field of cosmetics.
[0003] Pionein is highly active, but its effective concentration in cosmetics is low. The raw material supplier recommends a concentration of 0 to 0.0050%. It is internationally labeled as a restricted ingredient in cosmetics, and the added amount is below 0.0050%. Moreover, under certain conditions, Pionein is unstable and easily decomposes, affecting the effect of the product. Therefore, whether it is based on regulatory needs, the stability of Pionein, or its widespread use in cosmetics, its detection method should be established.
[0004] There is no mature detection method at present, and only liquid chromatography and electrochemical impedance spectroscopy are available abroad. Among them, high-performance liquid chromatography is not specific and sensitive, and there may be a risk of false positives due to matrix effects; electrochemical impedance spectroscopy is relatively complex. The existing method is mainly used in gel and spray cosmetics, and no research has been conducted on other cosmetic fields with complex matrices. Therefore, the present invention aims to establish a method for determining picolin in liquid matrix, emulsion matrix and cream matrix, which can be used as a basis for the detection method of picolin in cosmetics. Summary of the invention
[0005] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a method for detecting picolinamide in cosmetics and its application, which can accurately detect the content of picolinamide in liquid matrix, emulsion matrix and cream matrix.
[0006] To achieve the above object, the technical solution adopted by the present invention is:
[0007] In a first aspect, the present invention provides a method for detecting pyridine in cosmetics, comprising the following steps:
[0008] S1 Sample extraction: Mix the sample to be tested with the extracting solution evenly; the extracting solution is methanol solvent;
[0009] S2 Sample detection: The sample prepared in step S1 is detected by high performance liquid chromatography-tandem mass spectrometry; the conditions of the high performance liquid chromatography-tandem mass spectrometry are:
[0010] 1) Chromatographic conditions:
[0011] Chromatographic column: Shimadzu Shim-pack GIST C 18 (2.1×100mm, 3μm);
[0012] Mobile phase: Mobile phase A is a mixed aqueous solution of ammonium formate and formic acid;
[0013] Mobile phase B is a mixed solution of ammonium formate and formic acid in water and acetonitrile;
[0014] Elution mode: 0-10.0min, 75%-30%A;
[0015] 10.0~15.0min, 30%A;
[0016] 15.0~15.1min, 30%~75%A;
[0017] 15.1~20.0min, 75%A;
[0018] Flow rate: 0.1~0.6mL / min;
[0019] Column temperature: 20~60℃;
[0020] Injection volume: 0.5~4μL;
[0021] 2) Mass spectrometry conditions:
[0022] Ion source: electrospray ion source (ESI); scanning mode: positive ion mode; monitoring mode: multiple reaction monitoring (MRM) mode; interface voltage: 1.0 eV; interface temperature: 350°C; desolvation tube temperature: 250°C; nebulizing gas flow rate: 3.0 L / min; heating gas flow rate: 15.0 L / min; drying gas flow rate: 5.0 L / min.
[0023] As a preferred embodiment of the present invention, in step S1, the sample to be tested and the extract are mixed evenly and ultrasonic extraction is adopted, and the ultrasonic parameters are: power 200-800W, temperature 10-50°C, and time 10-50min. Preferably, the power can be 200W, 300W, 400W, 500W, 600W, 700W, 800W or any value within these numerical ranges; the temperature can be 10°C, 15°C, 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C or any value within these numerical ranges; the time can be 10min, 15min, 20min, 25min, 30min, 35min, 40min, 45min, 50min or any value within these numerical ranges.
[0024] As a preferred embodiment of the present invention, in step S1, the sample to be tested and the extract are uniformly mixed and extracted by ultrasonic extraction, and the ultrasonic parameters are: power 400-600W, temperature 20-40°C, time 20-40min.
[0025] As a preferred embodiment of the present invention, the step S1 further comprises a centrifugation step, and the supernatant is taken after the centrifugation.
[0026] As a preferred embodiment of the present invention, the concentration of ammonium formate in the mobile phase A in step S2 is 0.5-4.0 mmol / L, and the concentration of formic acid is 0.01-1.0% (v / v). Preferably, the concentration of ammonium formate can be 0.5 mmol / L, 1 mmol / L, 1.5 mmol / L, 2 mmol / L, 2.5 mmol / L, 3 mmol / L, 3.5 mmol / L, 4 mmol / L or any value within these numerical ranges; the concentration of formic acid can be 0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1%, 0.2%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0% or any value within these numerical ranges.
[0027] As a preferred embodiment of the present invention, in step S2, the concentration of ammonium formate in the mobile phase A is 1.0-3.0 mmol / L, and the concentration of formic acid is 0.2-0.7% (v / v).
[0028] As a preferred embodiment of the present invention, in step S2, the concentration of ammonium formate in the mobile phase B is 0.5-4.0 mmol / L, the concentration of formic acid is 0.01-1.0% (v / v), and the volume ratio of the mixed aqueous solution of ammonium formate and formic acid to acetonitrile is 10-80:920-990. Wherein, the mobile phase B is a mixed solution of the mixed aqueous solution of ammonium formate and formic acid and acetonitrile, that is, the mobile phase B is a mixed solution of the mobile phase A and acetonitrile. Preferably, the concentration of ammonium formate can be 0.5mmol / L, 1mmol / L, 1.5mmol / L, 2mmol / L, 2.5mmol / L, 3mmol / L, 3.5mmol / L, 4mmol / L or any value within these numerical ranges; the concentration of formic acid can be 0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1%, 0.2%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0% or any value within these numerical ranges. Preferably, the volume ratio of the mixed aqueous solution of ammonium formate and formic acid to acetonitrile can be 10:990, 20:980, 30:970, 40:960, 50:950, 60:940, 70:930, 80:920 or any value within these numerical ranges.
[0029] As a preferred embodiment of the present invention, in step S2, the concentration of ammonium formate in the mobile phase B is 1.0-3.0 mmol / L, the concentration of formic acid is 0.2-0.7% (v / v), and the volume ratio of the mixed aqueous solution of ammonium formate and formic acid to acetonitrile is 20-60:940-980.
[0030] As a preferred embodiment of the present invention, in step S2, the flow rate is 0.2-0.5 ml / min; the column temperature is 30-50°C; and the injection volume is 1-3 μL. Preferably, the flow rate can be 0.2 ml / min, 0.3 ml / min, 0.4 ml / min, 0.5 ml / min; the column temperature can be 30°C, 35°C, 40°C, 45°C, 50°C or any value within these numerical ranges; the injection volume can be 1 μL, 1.2 μL, 1.4 μL, 1.6 μL, 1.8 μL, 2 μL, 2.2 μL, 2.4 μL, 2.6 μL, 2.8 μL, 3 μL or any value within these numerical ranges.
[0031] As a preferred embodiment of the present invention, in step S2, the flow rate is 0.4 mL / min; the column temperature is 40° C.; and the injection volume is 2 μL.
[0032] In a second aspect, the present invention provides application of the method described in detecting pionin in cosmetics.
[0033] In a third aspect, the present invention provides the use of ammonium formate or formic acid, or a mixed aqueous solution of ammonium formate and formic acid, or a mixed solution of a mixed aqueous solution of ammonium formate and formic acid and acetonitrile in detecting picolin in cosmetics. The present invention is the first to use ammonium formate, formic acid and acetonitrile to construct a system for detecting the content of picolin in cosmetics. The detection system can accurately detect picolin in cosmetics with a relatively complex matrix, and has high sensitivity and a wide detection range.
[0034] In a fourth aspect, the present invention provides the use of methanol in extracting picolin in cosmetics. The present invention is the first to use methanol to extract picolin in cosmetics with a relatively complex matrix, and the extraction is complete and the yield is high.
[0035] Compared with the prior art, the present invention has the following beneficial effects:
[0036] The present invention fills the gap in the detection method of pionin on the market, and can provide a quality control basis for the application of pionin in cosmetics. The detection method of the present invention can accurately detect the content of pionin in liquid matrix, emulsion matrix and cream matrix. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1 This is the mass spectrum of the piaoning standard. DETAILED DESCRIPTION
[0038] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.
[0039] Example 1
[0040] 1. Dissolve the standard product of Pioneer in methanol to prepare the stock solution of the standard product of Pioneer; take samples and prepare the solution of the product to be tested. The products to be tested are two types of cosmetic toner, lotion and cream containing Pioneer on the market; accurately weigh 0.1g (accurate to 0.001g), use methanol solvent, ultrasonically extract for 30min at a power of 500W and a temperature of 30℃, take out and restore to room temperature, centrifuge for 10min, and take the supernatant for testing;
[0041] 2. Testing was performed using high performance liquid chromatography-tandem mass spectrometry, wherein the conditions of the high performance liquid chromatography-tandem mass spectrometry include:
[0042] Chromatographic conditions: Chromatographic column: Shimadzu Shim-pack GIST C 18 (2.1×100mm, particle size 3μm);
[0043] Mobile phase: A2.0mmol / L ammonium formate and 0.5% formic acid aqueous solution,
[0044] B The volume ratio of 2.0mmol / L ammonium formate + 0.5% formic acid aqueous solution to acetonitrile is 40:960;
[0045] Elution mode: 0-10.0min, 75%-30%A;
[0046] 10.0~15.0min, 30%A;
[0047] 15.0~15.1min, 30%~75%A;
[0048] 15.1~20.0min, 75%A,
[0049] The liquid phase elution is shown in Table 1:
[0050] Table 1: Liquid phase elution conditions
[0051] Time min A% B% 0.0 75 25 10.0 30 70 15.0 30 70 15.1 75 25 20 75 25
[0052] Flow rate: 0.4 mL / min;
[0053] Column temperature: 40°C;
[0054] Injection volume: 2 μL;
[0055] Mass spectrometry conditions: ion source: electrospray ion source (ESI); scanning mode: positive ion mode; monitoring mode: multiple reaction monitoring (MRM) mode; interface voltage: 1.0 eV; interface temperature: 350 °C; desolvation tube temperature: 250 °C; nebulizer gas flow rate: 3.0 L / min; heating gas flow rate: 15.0 L / min; drying gas flow rate: 5.0 L / min;
[0056] 3. Take six levels of piornine standard with mass concentrations of 0.5μg / L, 1μg / L, 2μg / L, 5μg / L, 10μg / L and 20μg / L and inject them into the instrument, and draw a standard curve with peak area y as the ordinate and mass concentration x as the abscissa;
[0057] 4. Inject the test solution into the instrument and detect it according to the above method. According to the standard curve in step 2, the content of picolinin in the test sample is obtained, and the spike recovery is performed.
[0058] Example 2
[0059] Except that in step 1, the ultrasonic conditions of the sample to be tested are: ultrasonic extraction for 50 min at a power of 200 W and a temperature of 50° C., the other conditions are the same as those in Example 1.
[0060] Example 3
[0061] Except that in step 1, the ultrasonic conditions of the sample to be tested are: ultrasonic extraction for 10 min at a power of 800 W and a temperature of 10° C., the other conditions are the same as those in Example 1.
[0062] Example 4
[0063] Except that in step 1, the ultrasonic conditions of the sample to be tested are: ultrasonic extraction for 20 min at a power of 600 W and a temperature of 20° C., the other conditions are the same as those in Example 1.
[0064] Example 5
[0065] Except that in step 1, the ultrasonic conditions of the sample to be tested are: ultrasonic extraction for 40 min at a power of 400 W and a temperature of 40° C., the other conditions are the same as those in Example 1.
[0066] Example 6
[0067] The chromatographic conditions in step 2 were the same as those in Example 1 except that the mobile phase was A 0.5 mmol / L ammonium formate and 0.01% formic acid aqueous solution, B 0.5 mmol / L ammonium formate + 0.01% formic acid aqueous solution and acetonitrile in a volume ratio of 10:990; flow rate: 0.1 mL / min; column temperature: 20° C.; injection volume: 0.5 μL.
[0068] Example 7
[0069] Except that the chromatographic conditions in step 2 are: mobile phase: A 4.0mmol / L ammonium formate and 1.0% formic acid aqueous solution, B 4.0mmol / L ammonium formate + 1.0% formic acid aqueous solution and acetonitrile volume ratio 80:920; flow rate: 0.6mL / min; column temperature: 60°C; injection volume: 4μL; others are consistent with Example 1.
[0070] Example 8
[0071] Except that the chromatographic conditions in step 2 are: mobile phase: A 1.0 mmol / L ammonium formate and 0.7% formic acid aqueous solution, B 1.0 mmol / L ammonium formate + 0.7% formic acid aqueous solution and acetonitrile volume ratio 60:940; flow rate: 0.5 mL / min; column temperature: 30°C; injection volume: 3.0 μL; others are consistent with Example 1.
[0072] Example 9
[0073] Except that the chromatographic conditions in step 2 are: mobile phase: A 3.0mmol / L ammonium formate and 0.2% formic acid aqueous solution, B 3.0mmol / L ammonium formate + 0.2% formic acid aqueous solution and acetonitrile volume ratio 20:980; flow rate: 0.2mL / min; column temperature: 50°C; injection volume: 1.0μL; others are consistent with Example 1.
[0074] Comparative Example 1
[0075] Except that the extraction solvent for the sample to be tested in step 1 is acetonitrile, other conditions are the same as those in Example 1.
[0076] Comparative Example 2
[0077] Except that the extraction solvent of the sample to be tested in step 1 is a mixed solution of methanol and acetonitrile, wherein the volume ratio of methanol to ethanol is 5:5, other conditions are the same as those in Example 1.
[0078] Comparative Example 3
[0079] Except that the extraction solvent for the sample to be tested in step 1 is ethanol, other conditions are the same as those in Example 1.
[0080] Comparative Example 4
[0081] The preparation method of the sample to be tested in step 1 is the same as that in Example 1 except that the ultrasonic extraction is performed at a power of 100 W and a temperature of 30° C. for 30 min.
[0082] Comparative Example 5
[0083] The preparation method of the sample to be tested in step 1 is the same as that in Example 1 except that the ultrasonic extraction is performed at a power of 900 W and a temperature of 30° C. for 30 min.
[0084] Comparative Example 6
[0085] The preparation method of the sample to be tested in step 1 is the same as that in Example 1 except that the ultrasonic extraction is performed at a power of 500 W and a temperature of 5° C. for 30 min.
[0086] Comparative Example 7
[0087] The preparation method of the sample to be tested in step 1 is the same as that in Example 1 except that the ultrasonic extraction is performed at a power of 500 W and a temperature of 55° C. for 30 min.
[0088] Comparative Example 8
[0089] The preparation method of the sample to be tested in step 1 is the same as that in Example 1 except that the ultrasonic extraction is performed at a power of 500 W and a temperature of 30° C. for 5 min.
[0090] Comparative Example 9
[0091] The preparation method of the sample to be tested in step 1 is the same as that in Example 1 except that the ultrasonic extraction is performed at a power of 500 W and a temperature of 30° C. for 55 min.
[0092] Comparative Example 10
[0093] Except that the chromatographic column in step 2 was changed to Agilent ZORBAX SB-Aq C 18 Except for (100×3.0 mm, 1.8 μm), the rest are consistent with Example 1.
[0094] Comparative Example 11
[0095] Except that the chromatographic column in step 2 was changed to Waters ACQUITY Except for HSS T3 (100 mm×2.1 mm, 1.8 μm), the others are the same as those in Example 1.
[0096] Comparative Example 12
[0097] Except that the chromatographic conditions in step 2 are as follows: mobile phase: A 2.0 mmol / L ammonium acetate and 0.5% acetic acid aqueous solution, the others are consistent with those in Example 1.
[0098] Comparative Example 13
[0099] The chromatographic conditions in step 2 are the same as those in Example 1 except that the mobile phase is a volume ratio of 2.0 mmol / L ammonium acetate + 0.5% acetic acid aqueous solution to acetonitrile of 40:960.
[0100] Comparative Example 14
[0101] The chromatographic conditions in step 2 are the same as those in Example 1 except that the mobile phase is B 2.0mmol / L ammonium formate + 0.5% formic acid aqueous solution and the volume ratio of methanol is 40:960.
[0102] Comparative Example 15
[0103] The chromatographic conditions in step 2 are the same as those in Example 1 except that the mobile phase is B 2.0mmol / L ammonium formate + 0.5% formic acid aqueous solution and ethanol in a volume ratio of 40:960.
[0104] Comparative Example 16
[0105] Except that the chromatographic conditions in step 2 are: mobile phase A: methanol; mobile phase B: water; the rest are the same as those in Example 1.
[0106] Comparative Example 17
[0107] Except that the chromatographic conditions in step 2 are: mobile phase A: acetonitrile; mobile phase B: water; the rest are the same as those in Example 1.
[0108] Comparative Example 18
[0109] The chromatographic conditions in step 2 are the same as those in Example 1 except that the mobile phase is A 0.4 mmol / L ammonium formate and 0.005% formic acid aqueous solution, B 0.4 mmol / L ammonium formate + 0.005% formic acid aqueous solution and acetonitrile in a volume ratio of 40:960.
[0110] Comparative Example 19
[0111] The chromatographic conditions in step 2 are the same as those in Example 1 except that the mobile phase is A 4.5 mmol / L ammonium formate and 1.5% formic acid aqueous solution, B 4.5 mmol / L ammonium formate + 1.5% formic acid aqueous solution and acetonitrile in a volume ratio of 40:960.
[0112] Comparative Example 20
[0113] Except that the chromatographic conditions in step 2 are: the volume ratio of B 2.0mmol / L ammonium formate + 0.5% formic acid aqueous solution to acetonitrile is 5:995; the rest are the same as those in Example 1.
[0114] Comparative Example 21
[0115] Except that the chromatographic conditions in step 2 are: the volume ratio of B 2.0mmol / L ammonium formate + 0.5% formic acid aqueous solution to acetonitrile is 85:915; the rest are consistent with Example 1.
[0116] Comparative Example 22
[0117] Except for the chromatographic conditions in step 2: flow rate 0.7 mL / min; the others are consistent with Example 1.
[0118] Comparative Example 23
[0119] Except for the chromatographic conditions in step 2: flow rate 0.05 mL / min; the others are consistent with Example 1.
[0120] Comparative Example 24
[0121] Except for the chromatographic conditions in step 2: column temperature 70°C; the others are the same as in Example 1.
[0122] Comparative Example 25
[0123] Except for the chromatographic conditions in step 2: column temperature 10°C; the others are the same as in Example 1.
[0124] Comparative Example 26
[0125] Except that the chromatographic conditions in step 2 are: injection volume: 5 μL; the rest are consistent with Example 1. Comparative Example 27
[0126] Except for the chromatographic conditions in step 2: injection volume: 0.1 μL; the others are consistent with Example 1.
[0127] Comparative Example 28
[0128] Except for the detection by high performance liquid chromatography in step 2, the rest is the same as that in Example 1.
[0129] Comparative Example 29
[0130] Except for the following liquid phase detection conditions and parameters used in step 2, the others are consistent with Example 1; Chromatographic column: C 18 , 50×2.1mm (particle size 1.7μm);
[0131] Mobile phase: A: acetonitrile;
[0132] B: 0.1% formic acid solution;
[0133] Flow rate: 0.3ml / min;
[0134] Column temperature: 35°C;
[0135] Injection volume: 1 μL.
[0136] The elution method is shown in Table 2 below:
[0137] Table 2: Liquid phase elution conditions
[0138] Time min A% B% 0.0 40 60 1.0 40 60 5.0 100 0 8.0 100 0 8.1 40 60 10 40 60
[0139] Comparative Example 30
[0140] Except for the following liquid phase detection conditions and parameters used in step 2, the others are consistent with Example 1; chromatographic column: SCX:C 18 =1:4, 150×2.0mm (particle size 5.0μm);
[0141] Mobile phase: A: 50mmol / L ammonium formate (containing 0.1% formic acid solution);
[0142] B: acetonitrile;
[0143] The elution method is shown in Table 3 below:
[0144] Flow rate: 0.3 mL / min;
[0145] Column temperature: 30°C;
[0146] Injection volume: 10 μL;
[0147] Table 3: Liquid phase elution conditions
[0148] Time min A% B% 0.0 45 55 3.0 45 55 10.0 10 90 13.0 10 90 13.1 45 55 20 45 55
[0149] The results of sample detection by the detection method constructed in the embodiment and the comparative example are compared.
[0150] The embodiment and comparative example were used to conduct a spiked recovery experiment on a commercially available picolinine sample, and the recovery rate was calculated to verify the reliability of the detection method.
[0151] Table 4: Comparison results of standard curve, correlation coefficient, detection limit, quantitative line and spiked recovery rate of detection method constructed by Example and Comparative Example
[0152]
[0153]
[0154] Comparison of Comparative Examples 10 to 11 with Examples 1 and 6 to 9 shows that after replacing other types of chromatographic columns, the retention time of piaoning is shifted back or the peak shape is incomplete, the correlation coefficient of the standard curve is not as good as that of Example 1, and the detection limit and quantitative limit are high, and the method recovery rate is poor. Therefore, the chromatographic columns selected in Examples 1 and 6 to 9 have better separation and quantitative effect of piaoning.
[0155] Comparison of Comparative Examples 12 to 21 with Examples 1 and 6 to 9 shows that after changing the mobile phase composition and the ratio between mobile phases A and B, not only the peak time of piaoning is shifted backward or forward or the separation is poor and no peak appears, but also the correlation coefficient of the standard curve is poor, the detection limit and quantitative limit are high, and the method recovery rate is poor, all of which will make the detection results inaccurate.
[0156] Comparison of Comparative Examples 22 to 27 with Examples 1 and Examples 6 to 9 shows that only under the chromatographic column conditions of the embodiments, the peak time of piaoning is regular, the correlation coefficient of the standard curve is good, the method recovery rate is good, and the detection limit and quantification limit can meet the requirements of low-concentration piaoning detection.
[0157] From the comparison between Comparative Example 28 and Example 1, it can be seen that after the HPLC method is replaced, the detection limit is significantly higher than that of the HPLC-MS / MS method.
[0158] Comparison of Comparative Examples 29-30 with Example 1 shows that the mass spectrometry methods of other existing quaternary ammonium salts cannot detect picolin or the correlation coefficient of the standard curve is not high, the detection limit and the quantitative limit are too high, the recovery rate is poor, and the detection requirements of low-concentration picolin cannot be met.
[0159] The test results of the content of piornine in 6 commercially available samples containing piornine are shown in the following table:
[0160] Table 5 Detection results of the content of pionein in commercially available samples containing pionein
[0161]
[0162]
[0163] Note: ND means not detected. The spike recovery rate is within 80-120%, indicating that the accuracy and precision of the analytical method are good. Spiked recovery rate = (spike sample measurement value - sample measurement value) ÷ spike amount × 100%.
[0164] Comparison of Comparative Examples 1 to 3 with Example 1 shows that, after changing the extraction solvent of the sample to be tested, there will be a problem of incomplete extraction of pionin, which will eventually lead to the situation that the target substances in some products are not detected.
[0165] By comparing Comparative Examples 4 to 9 with Examples 1 to 5, it can be concluded that only under the sample pretreatment conditions of the present invention can the picornine in the sample to be tested be completely extracted. If the extraction conditions of the present invention are exceeded, the picornine may be decomposed under the conditions of a long-term high-temperature ultrasonic link, resulting in the detection data being inconsistent with the facts; if the experimental conditions are lower than the experimental conditions of the present invention, the extraction is incomplete, resulting in a low result.
[0166] Comparison of Comparative Example 28 with Examples 1 to 5 shows that the detection limit of picornine by the HPLC method cannot meet the detection requirements of commercially available products. The method of the present invention can accurately detect picornine at low addition levels.
Claims
1. A method for detecting pyridine in cosmetics, characterized in that: The steps include: S1 Sample extraction: Mix the sample to be tested with the extracting solution evenly; the extracting solution is methanol solvent; S2 Sample detection: Use high performance liquid chromatography-tandem mass spectrometry to detect the sample prepared in step S1; the conditions of the high performance liquid chromatography-tandem mass spectrometry are: 1) Chromatographic conditions: Chromatographic column: Shimadzu Shim-pack GIST C 18 (2.1×100mm, 3μm); Mobile phase: Mobile phase A is a mixed aqueous solution of ammonium formate and formic acid; Mobile phase B is a mixed solution of ammonium formate and formic acid in water and acetonitrile; Elution mode: 0-10.0min, 75%-30%A; 10.0~15.0min, 30%A; 15.0~15.1min, 30%~75%A; 15.1~20.0min, 75%A; Flow rate: 0.1~0.6mL / min; Column temperature: 20~60℃; Injection volume: 0.5~4μL; 2) Mass spectrometry conditions: Ion source: electrospray ion source (ESI); scanning mode: positive ion mode; monitoring mode: multiple reaction monitoring (MRM) mode; interface voltage: 1.0 eV; interface temperature: 350°C; desolvation tube temperature: 250°C; nebulizing gas flow rate: 3.0 L / min; heating gas flow rate: 15.0 L / min; drying gas flow rate: 5.0 L / min.
2. The method according to claim 1, characterized in that In the step S1, the sample to be tested and the extract are mixed evenly and then extracted by ultrasonic method. The parameters of the ultrasonic method are as follows: power 200-800W, temperature 10-50°C, and time 10-50min.
3. The method according to claim 2, characterized in that In the step S1, the sample to be tested and the extract are mixed evenly and ultrasonic extraction is performed. The ultrasonic parameters are: power 400-600W, temperature 20-40°C, and time 20-40min.
4. The method according to claim 1, characterized in that The step S1 also includes a centrifugation step, and the supernatant is taken after centrifugation.
5. The method according to claim 1, characterized in that In step S2, the concentration of ammonium formate in the mobile phase A is 0.5-4.0 mmol / L, and the concentration of formic acid is 0.01-1.0% (v / v); Preferably, in step S2, the concentration of ammonium formate in the mobile phase A is 1.0-3.0 mmol / L, and the concentration of formic acid is 0.2-0.7% (v / v).
6. The method according to claim 1, characterized in that In step S2, the concentration of ammonium formate in the mobile phase B is 0.5-4.0 mmol / L, the concentration of formic acid is 0.01-1.0% (v / v), and the volume ratio of the mixed aqueous solution of ammonium formate and formic acid to acetonitrile is 10-80:920-990; Preferably, in step S2, the concentration of ammonium formate in the mobile phase B is 1.0-3.0 mmol / L, the concentration of formic acid is 0.2-0.7% (v / v), and the volume ratio of the mixed aqueous solution of ammonium formate and formic acid to acetonitrile is 20-60:940-980.
7. The method according to claim 1, characterized in that In the step S2, the flow rate is 0.2-0.5 ml / min, the column temperature is 30-50° C., and the injection volume is 1-3 μL.
8. Use of the method according to claims 1 to 7 in detecting pionin in cosmetics.
9. Application of ammonium formate or formic acid, or a mixed aqueous solution of ammonium formate and formic acid, or a mixed solution of a mixed aqueous solution of ammonium formate and formic acid and acetonitrile in the detection of pionin in cosmetics.
10. Application of methanol in the extraction of pyridine in cosmetics.
